MIRNA THERAPEUTICS INC's ticker is MIRN and the CUSIP is 60470J103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $271,000 | -30.7% | 160,006 | -10.3% | 0.00% | – |
Q1 2017 | $391,000 | +40.1% | 178,387 | +15.2% | 0.00% | – |
Q4 2016 | $279,000 | +19.7% | 154,867 | +31.1% | 0.00% | – |
Q3 2016 | $233,000 | -43.9% | 118,171 | +21.5% | 0.00% | – |
Q2 2016 | $415,000 | -2.4% | 97,271 | 0.0% | 0.00% | – |
Q1 2016 | $425,000 | -27.6% | 97,271 | +3.6% | 0.00% | – |
Q4 2015 | $587,000 | – | 93,903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Management VIII, L.L.C. | 2,974,812 | $5,355,000 | 3.01% |
NEA Management Company, LLC | 2,974,811 | $5,355,000 | 0.21% |
SABBY MANAGEMENT, LLC | 100,200 | $180,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 45,000 | $81,000 | 0.00% |
FRANKLIN RESOURCES INC | 1,384,073 | $2,491,000 | 0.00% |
BlackRock Investment Management, LLC | 1,632 | $3,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 40,186 | $72,000 | 0.00% |
BlackRock Fund Advisors | 23,861 | $43,000 | 0.00% |
VANGUARD GROUP INC | 154,867 | $279,000 | 0.00% |
UBS Group AG | 88 | $0 | 0.00% |